A new Schaeffer Center study comparing Medicare Part D prescription drug prices with those paid by Costco members finds that the federal government overpaid on roughly half of the most common generic medicines in 2018.
Medicare and Medicaid
Other featured articles
USC Research Shows Costco Beats Medicare in Generic Drug Savings Nearly 50% of the Time
Intermediaries negotiate good prices, but lack incentives to pass savings to beneficiaries and taxpayers.
Access to the 340B Drug Pricing Program: Is There Evidence of Strategic Hospital Behavior?
Some hospitals adjust their measure that identifies hospitals that treat a disproportionate share of low-income patients to gain 340B eligibility.
Cost- Effectiveness of Total State Coverage for Hepatitis C Medications
A Medicaid-Medicare partnership could cover lifesaving hepatitis C medications — and still save $1 to $1.1 billion over 25 years.
The Effects of Vertically Integrated Care on Health Care Use and Outcomes in Inpatient Rehabilitation Facilities
Receiving vertically integrated care in hospital-based inpatient rehabilitation facilities shortens institutional length of stay while maintaining or improving health outcomes.
About this section
The nation’s growing debt threatens Medicare and Medicaid, which have helped countless Americans and reduced poverty. Schaeffer Center researchers work with legislators on a bipartisan basis to bolster these vital systems, making them more efficient and effective.